ARTICLE | Company News
InterveXion, Medicago deal
June 13, 2005 7:00 AM UTC
Medicago will use its Proficia protein technology to produce clinical supplies of a monoclonal antibody from InterveXion to treat phencyclidine (PCP) addiction. InterveXion is developing the antibody ...